National Survey on Gastroesophageal Reflux Disease (GERD) Patients (LINEA)

AstraZeneca

Status: Completed

Conditions: GERD

Study type: Observational

Funder types: Industry

Identifiers

NCT00695838

NIS-GFR-DUM-2007/3

Details and patient eligibility

About

The purpose of this observational study is to assess the impact of abdominal fat on severity and frequency of GERD symptoms .

Enrollment: 5,084 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Male or female > or = 18 years old
• Patient with symptomatic GERD
• Without PPI or H2 antagonist treatment during the 3 previous months
• Agree to take part in this study

Exclusion criteria

• Pregnant women

Trial design

5,084 participants in 1 patient group

1